Targeting insulin resistance in type 2 diabetes via immune modulation of cord blood-derived multipotent stem cells (CB-SCs) in stem cell educator therapy: phase I/II clinical trial. [electronic resource]
Producer: 20140204Description: 160 p. digitalISSN:- 1741-7015
- Adult
- Aged
- Coculture Techniques
- Diabetes Mellitus, Type 2 -- immunology
- Female
- Fetal Blood -- immunology
- Follow-Up Studies
- Humans
- Hypoglycemic Agents -- administration & dosage
- Immunomodulation -- drug effects
- Insulin Resistance -- immunology
- Male
- Middle Aged
- Molecular Targeted Therapy -- methods
- Multipotent Stem Cells -- immunology
- Stem Cell Transplantation -- methods
- Transplantation, Autologous
No physical items for this record
Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.